Higher Grade Disease at Prostatectomy With Surveillance

Share this content:
Higher Grade Disease at Prostatectomy With Surveillance
Higher Grade Disease at Prostatectomy With Surveillance

FRIDAY, Oct. 21, 2016 (HealthDay News) -- For men with low-risk prostate cancer, those who enter active surveillance have higher grade of disease at prostatectomy, but no difference in other adverse pathological outcomes, compared to those undergoing immediate surgery, according to a study published in the November issue of The Journal of Urology.

Gregory B. Auffenberg, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a prospective cohort study involving two groups of patients with National Comprehensive Cancer Network low-risk prostate cancer who chose either initial active surveillance and went on to delayed prostatectomy or immediate prostatectomy. Radical prostatectomy Gleason scores, and rates of extraprostatic disease, positive surgical margins, seminal vesicle invasion, and lymph node metastases were compared between the groups.

The researchers found that 6 percent of 1,359 low-risk men choosing initial surveillance transitioned to prostatectomy during a median follow-up of 506 days. Men undergoing delayed surgery were more likely to have Gleason score 7 or greater disease (69.2 versus 48.8 percent; P = 0.004); however, they were no more likely to have positive margins, extraprostatic extension, seminal vesicle invasion, or lymph node metastases.

"Patients with low-risk prostate cancer who enter active surveillance have higher grade disease at prostatectomy compared to those undergoing immediate surgery," the authors write. "However, the lack of difference in other adverse pathological outcomes suggests preservation of the window of curability."

One author disclosed financial ties to Myriad Genetics.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Gene Tx Approved for Certain Types of B-Cell Lymphoma

Gene Tx Approved for Certain Types of B-Cell ...

First such treatment for certain types of non-Hodgkin lymphoma

Uninsurance Down by One-Third for Cancer Diagnoses in 2014

Uninsurance Down by One-Third for Cancer Diagnoses in ...

Significant decreases in uninsurance seen across all stages and sites assessed in first year of ACA

Diabetes Ups Risk of MACE in Acute Coronary Syndromes

Diabetes Ups Risk of MACE in Acute Coronary ...

Diabetes, but not pre-diabetes, tied to increased risk of major adverse cardiac events in adjusted model

is free, fast, and customized just for you!

Already a member?

Sign In Now »